作者:Michael L. Edwards、N. J. Prakash、D. M. Stemerick、S. P. Sunkara、A. J. Bitonti、G. F. Davis、J. A. Dumont、P. Bey
DOI:10.1021/jm00167a014
日期:1990.5
tetraamines derived from 1,8-diaminooctane was prepared and tested as antitumor agents. The reaction of 1,8-diaminooctane with acrylonitrile gave N,N'-bis(cyanoethyl)-1,8-diaminooctane, which was reduced to tetraamine 20. Alkylation of the terminal nitrogen atoms of the tetra-Boc derivative of this compound by methyl or ethyl halide followed by removal of the Boc groups gave the bis(alkyl)polyamines 26a
制备了一系列衍生自1,8-二氨基辛烷的四胺并作为抗肿瘤剂进行了测试。1,8-二氨基辛烷与丙烯腈的反应得到N,N′-双(氰基乙基)-1,8-二氨基辛烷,将其还原成四胺20。该化合物的四-Boc衍生物的末端氮原子的烷基化通过甲基或乙基卤化物,然后除去Boc基团,分别得到双(烷基)多胺26a和26b。这三种化合物在小鼠L1210白血病模型中显示出有希望的抗肿瘤活性。多胺氧化酶抑制剂的共同给药增强了抗肿瘤活性。